Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries recorded a 480% year-on-year (YoY) surge in its net profits before taxes, logging EGP 23.73 million during the first eight months of fiscal year 2020/2021, compared to EGP 4.09 million.
The company’s revenues grew to EGP 360.32 million in the eight-month period ended 28 February, compared to EGP 334.2 million in the corresponding period a year earlier, according to a bourse disclosure on Wednesday.
During the first half (H1) of FY20/21, Memphis Pharmaceutical logged net profits before taxes of EGP 18.81 million, up from EGP 3.34 million in H1 of FY19/20.
